<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02489162</url>
  </required_header>
  <id_info>
    <org_study_id>MiMuMS</org_study_id>
    <nct_id>NCT02489162</nct_id>
  </id_info>
  <brief_title>The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis Patients</brief_title>
  <acronym>MyotonPRO</acronym>
  <official_title>The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the research is to determine whether the MyotonPRO has a valid and reliable
      application in facial, head and neck surgery. In addition, the study aims to compare this new
      technology with current electromyography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Facial paralysis has significant aesthetic, functional and psycho-social morbidity. The
      diagnosis and monitoring of neuromuscular recovery is limited to clinical examination,
      electromyography (EMG) and electroneurography (ENoG). EMG and ENoG is invasive for the
      patient and has practical and cost disadvantages. The MyotonPRO is a handheld device, which
      is pain-free and quick to use. Therefore this research is assessing MyotonPRO technology for
      this clinical application and may be effective at evaluating rehabilitative and surgical
      interventions. Phase 1 - Variation of measurements Phase 2 - Mimic muscle dysfunction
      assessment Phase 3 - Peri-operative Mimic and temporalis muscle assessment Phase 4 - Phase 3
      including electromyography Phase 5 - Temporalis and mimic muscle assessment following facial
      reanimation surgery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle tone (Hz)</measure>
    <time_frame>12 months</time_frame>
    <description>Determine the feasibility of the MyotonPRO for assessing biomechanical properties of mimic muscles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stiffness (N/m)</measure>
    <time_frame>12 months</time_frame>
    <description>Determine the feasibility of the MyotonPRO for assessing biomechanical properties of mimic muscles.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>elasticity (Logarithmic decrement)</measure>
    <time_frame>12 months</time_frame>
    <description>Determine the feasibility of the MyotonPRO for assessing biomechanical properties of mimic muscles.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Facial Nerve Palsy</condition>
  <arm_group>
    <arm_group_label>MyotonPRO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental: Measurement of biomechanical properties of mimic muscles on the ipsilateral palsy side with the healthy contralateral side ( case - control design)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-invasive electromyography (EMG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparing experimental intervention with gold standard</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MyotonPRO</intervention_name>
    <description>MyotonPRO measurements of the biomechanical properties of facial mimic muscles</description>
    <arm_group_label>MyotonPRO</arm_group_label>
    <arm_group_label>Non-invasive electromyography (EMG)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-invasive electromyography (EMG)</intervention_name>
    <description>Gold standard technique for measuring muscle</description>
    <arm_group_label>MyotonPRO</arm_group_label>
    <arm_group_label>Non-invasive electromyography (EMG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. unilateral peripheral facial nerve palsy

          2. Mental capacity to give consent

          3. The patient is able to sit independently

        Exclusion Criteria:

          1. Adults who have undertaken strenuous exercise within the last twenty-four hours

          2. Adults taking prescription medication with a known effect on the mechanical properties
             of muscle (e.g. benzodiazepines) or receiving antispasmodic medications (e.g.
             botulinum A toxin)

          3. Adults with poor mobility (unable to lie prone).

          4. Adults with a body mass index (BMI) &gt;30 kg/m2 . Muscle measurements may be inaccurate
             with excessive subcutaneous tissue
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Blythe, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>European Face Centre, Universitair Ziekenhuis Brussel and University of Southhampton</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurice Mommaerts, Prof.Dr.Mult</last_name>
    <role>Study Chair</role>
    <affiliation>European Face Centre, Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Labb√©, MD</last_name>
    <role>Study Director</role>
    <affiliation>Saint Martin Private Hospital Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veerle Van Mossevelde, Data Nurse</last_name>
    <phone>+3224763134</phone>
    <email>veerle.vanmossevelde@uzbrussel.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veerle Van Mossevelde, Data Nurse</last_name>
      <phone>+3224763134</phone>
      <email>veerle.vanmossevelde@uzbrussel.be</email>
    </contact>
    <investigator>
      <last_name>John N Blythe, FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maurice Y Mommaerts, Prof.Dr.Mult</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Veerle Van Mossevelde</investigator_full_name>
    <investigator_title>Data nurse</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Facial Paralysis</mesh_term>
    <mesh_term>Bell Palsy</mesh_term>
    <mesh_term>Facial Nerve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

